High rates of financial toxicity and time toxicity in patients receiving chimeric antigen receptor therapy and bispecific antibodies for lymphoma and multiple myeloma: A prospective mixed methods study.

Steven T. Rosen, Murali Janakiram, Annie Xiao et al.|Blood|2025

Cited by 1